| Primary |
| Bipolar Disorder |
23.2% |
| Depression |
15.9% |
| Psychotic Disorder |
12.3% |
| Anxiety |
5.8% |
| Major Depression |
5.1% |
| Restlessness |
4.3% |
| Obsessive-compulsive Disorder |
3.6% |
| Prophylaxis Of Neural Tube Defect |
3.6% |
| Schizophrenia |
3.6% |
| Schizophrenia, Paranoid Type |
3.6% |
| Dependent Personality Disorder |
2.9% |
| Anxiety Disorder |
2.2% |
| Borderline Personality Disorder |
2.2% |
| Hypothyroidism |
2.2% |
| Insomnia |
2.2% |
| Antidepressant Therapy |
1.4% |
| Attention Deficit/hyperactivity Disorder |
1.4% |
| Bipolar I Disorder |
1.4% |
| Deafness Neurosensory |
1.4% |
| Infertility Female |
1.4% |
|
| Vomiting |
12.2% |
| Weight Increased |
9.8% |
| Drug Interaction |
7.3% |
| Leukopenia |
7.3% |
| Respiratory Depression |
7.3% |
| Suicide Attempt |
7.3% |
| Anaemia |
4.9% |
| Exposure During Pregnancy |
4.9% |
| Off Label Use |
4.9% |
| Somnolence |
4.9% |
| Subileus |
4.9% |
| Thrombocytopenia |
4.9% |
| Cataract |
2.4% |
| Cleft Lip And Palate |
2.4% |
| Deep Vein Thrombosis |
2.4% |
| Electrocardiogram Qt Prolonged |
2.4% |
| Encephalopathy |
2.4% |
| Erythema Multiforme |
2.4% |
| Galactorrhoea |
2.4% |
| Gamma-glutamyltransferase Increased |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
21.6% |
| Depression |
17.9% |
| Bipolar Disorder |
15.7% |
| Psychotic Disorder |
10.8% |
| Major Depression |
7.4% |
| Hypothyroidism |
3.7% |
| Sleep Disorder Therapy |
3.7% |
| Anxiety Disorder |
2.5% |
| Borderline Personality Disorder |
2.5% |
| Hypertension |
1.9% |
| Nervousness |
1.9% |
| Palpitations |
1.9% |
| Prophylaxis Of Neural Tube Defect |
1.9% |
| Dependent Personality Disorder |
1.3% |
| Antidepressant Therapy |
1.0% |
| Restlessness |
1.0% |
| Angiotensin Converting Enzyme |
0.8% |
| Cardiac Disorder |
0.8% |
| Gastrointestinal Disorder |
0.8% |
| Obsessive-compulsive Disorder |
0.8% |
|
| Erythema Multiforme |
13.4% |
| Restless Legs Syndrome |
11.0% |
| Dysarthria |
9.8% |
| Speech Disorder |
8.5% |
| Completed Suicide |
6.1% |
| Delirium |
6.1% |
| Influenza Like Illness |
6.1% |
| Weight Increased |
6.1% |
| Polyhydramnios |
4.9% |
| Pre-eclampsia |
3.7% |
| Premature Baby |
3.7% |
| Suicide Attempt |
3.7% |
| Tachycardia |
3.7% |
| Hair Growth Abnormal |
2.4% |
| Persistent Foetal Circulation |
2.4% |
| Subileus |
2.4% |
| Urinary Retention |
2.4% |
| Cleft Lip And Palate |
1.2% |
| Galactorrhoea |
1.2% |
| Nausea |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
66.7% |
| Hypertension |
9.5% |
| Psoriasis |
9.5% |
| Anxiolytic Therapy |
4.8% |
| Depression |
4.8% |
| Therapeutic Procedure |
4.8% |
|
| Stupor |
62.5% |
| Psychotic Disorder |
25.0% |
| Sudden Hearing Loss |
12.5% |
|
| Interacting |
| Product Used For Unknown Indication |
26.1% |
| Anxiety |
17.4% |
| Depression |
17.4% |
| Hypochondriasis |
17.4% |
| Hypertension |
8.7% |
| Schizophrenia |
8.7% |
| Schizophrenia Simple |
4.3% |
|
| Sinus Tachycardia |
19.0% |
| Somnambulism |
19.0% |
| Drug Interaction |
14.3% |
| Subileus |
14.3% |
| Vomiting |
14.3% |
| Galactorrhoea |
9.5% |
| Somnolence |
4.8% |
| Stasis Dermatitis |
4.8% |
|
